Autor: |
L, Roznovský, A, Kloudová, L, Kabieszová, V, Dedek, I, Orságová, A, Zjevíková |
Jazyk: |
čeština |
Rok vydání: |
2007 |
Předmět: |
|
Zdroj: |
Klinicka mikrobiologie a infekcni lekarstvi. 13(2) |
ISSN: |
1211-264X |
Popis: |
Liver transplantation was performed in 3 patients with hepatitis B infection in 1999-2004 years. Combination of hepatitis B immunoglobulin (HBIg) and lamivudine are used for prevention of hepatitis B recurrence. HBIg is administered in dose 2 000 international units (IU) with tendency to maintain anti-HBs antibodies above 100 IU/litre. Average interval between HBIg administrations was 22, 32 and 32 days, yearly price of treatment was 0.45-0.65 million Czech crowns. Three patients with HBIg and lamivudine therapy are still without recurrence of hepatitis B at the end of 2006 year. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|